Literature DB >> 1797897

Thrombolytic therapy soon after left heart catheterization--is it safe?

J C García-Rubira1, V López, J Rojas, J T García-Martínez, J M Cruz.   

Abstract

Puncture of a femoral artery for left heart catheterization is considered a relative contraindication for thrombolytic therapy for some days. We treated 9 patients with systemic thrombolysis who had undergone left heart catheterization in the previous hours. Four patients developed a large hematoma, but only 1 required transfusion. We suggest that thrombolytic therapy can be administered soon after left heart catheterization by the femoral approach, provided that continuous care can be taken over the puncture site.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1797897     DOI： 10.1007/BF01690777

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  9 in total

1.  Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.

Authors:  R L Rothbard; J L Anderson; P G Fitzpatrick; R A Hakworthy; S G Sorensen; V J Marder
Journal:  Clin Cardiol       Date:  1990-03       Impact factor: 2.882

2.  Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations.

Authors:  G J Davies; S Chierchia; A Maseri
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

3.  Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

Authors:  K L Neuhaus; U Tebbe; M Gottwik; M A Weber; W Feuerer; W Niederer; W Haerer; F Praetorius; K D Grosser; W Huhmann
Journal:  J Am Coll Cardiol       Date:  1988-09       Impact factor: 24.094

Review 4.  Expanding indications for the use of thrombolytic agents in acute myocardial infarction.

Authors:  S Yusuf
Journal:  Clin Cardiol       Date:  1990-03       Impact factor: 2.882

5.  Bleeding after thrombolysis in acute myocardial infarction.

Authors:  H H Erlemeier; W Zangemeister; L Burmester; J Schofer; D G Mathey; W Bleifeld
Journal:  Eur Heart J       Date:  1989-01       Impact factor: 29.983

6.  Results of high dose intravenous urokinase for acute myocardial infarction.

Authors:  T C Wall; H R Phillips; R S Stack; S Mantell; L Aronson; J Boswick; K Sigmon; M DiMeo; D Chaplin; D Whitcomb
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

Review 7.  Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction.

Authors:  S Sherry; V J Marder
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

8.  Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

9.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.